Search Count: 15
 |
Crystal Structure Of E. Coli Mlte With Bound Bulgecin And Murodipeptide
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2012-10-24 Classification: LYASE/LYASE INHIBITOR Ligands: BLG, SO4 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2012-10-24
Ligands: BLG, SO4
 |
2.4 A Crystal Structure Of E. Coli Mlte-E64Q With Bound Chitopentaose
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2012-10-24 Classification: LYASE |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2012-10-24
 |
1.9 A Crystal Structure Of E. Coli Mlte-E64Q With Bound Chitopentaose
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2012-10-24 Classification: LYASE Ligands: CL |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2012-10-24
Ligands: CL
 |
Crystal Structure Of Lytic Transglycosylase Mlte From Eschericha Coli
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2012-07-25 Classification: LYASE Ligands: SO4 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2012-07-25
Ligands: SO4
 |
Crystal Structure Of 3-Hydroxyanthranilate 3,4-Dioxygenase From Bovine Kidney
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:2.51 Å Release Date: 2009-06-09 Classification: OXIDOREDUCTASE Ligands: FE |
Organism: Bos taurus
Method: X-RAY DIFFRACTION
Release Date: 2009-06-09
Ligands: FE
 |
Crystal Structure Of Transthyretin Variant Y114H
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2009-04-07 Classification: TRANSPORT PROTEIN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2009-04-07
 |
Crystal Structure Of The Transthyretin-Retinol Binding Protein-Fab Complex
Organism: Homo sapiens, Mus musculus
Method: X-RAY DIFFRACTION Resolution:3.38 Å Release Date: 2008-11-11 Classification: TRANSPORT PROTEIN/IMMUNE SYSTEM Ligands: RTL |
Organism: Homo sapiens, Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2008-11-11
Ligands: RTL
 |
Crystal Structure Of Transthyretin Variant V20S
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2008-11-11 Classification: TRANSPORT PROTEIN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2008-11-11
 |
Crystal Structure Of The Complex Between Rhodanese And Lipoate
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2000-12-13 Classification: TRANSFERASE Ligands: LPB |
Organism: Bos taurus
Method: X-RAY DIFFRACTION
Release Date: 2000-12-13
Ligands: LPB
 |
Sulfur-Substituted Rhodanese (Orthorhombic Form)
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 1999-04-27 Classification: TRANSFERASE |
Organism: Bos taurus
Method: X-RAY DIFFRACTION
Release Date: 1999-04-27
 |
N-Terminally Truncated Rhodanese
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 1999-04-27 Classification: TRANSFERASE |
Organism: Bos taurus
Method: X-RAY DIFFRACTION
Release Date: 1999-04-27
 |
Sulfur-Substituted Rhodanese
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:1.36 Å Release Date: 1998-01-21 Classification: TRANSFERASE |
Organism: Bos taurus
Method: X-RAY DIFFRACTION
Release Date: 1998-01-21
 |
Annexin Iv
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 1998-01-14 Classification: CALCIUM/PHOSPHOLIPID-BINDING PROTEIN |
Organism: Bos taurus
Method: X-RAY DIFFRACTION
Release Date: 1998-01-14
 |
Rhodanese (Thiosulfate: Cyanide Sulfurtransferase)
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 1996-08-01 Classification: TRANSFERASE |
Organism: Bos taurus
Method: X-RAY DIFFRACTION
Release Date: 1996-08-01
 |
Active Site Structural Features For Chemically Modified Forms Of Rhodanese
Organism: Bos taurus
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 1995-10-15 Classification: SULFURTRANSFERASE Ligands: ACT |
Organism: Bos taurus
Method: X-RAY DIFFRACTION
Release Date: 1995-10-15
Ligands: ACT